Patent ID: 6531511
Filing Date: 2003-03-11
Classification: A61K,A61P,C07C,C07D

Abstract:
A method of treating a condition treatable by antagonism of the N-methyl-D-aspartate receptor, comprising administering to a subject suffering from said condition a pharmaceutically effective amount of a compound of the formula (1): wherein R1, R2, R3 , R4, R5 and R6 are independently selected from hydrogen, alkyl and aryl, or a pharmaceutically acceptable salt thereof, with the proviso that wherein R1 to R4 and R6 are hydrogen, R5 is not selected from CH2CH2NHSO2CH3, CH2CH2NHSO2CF3 and methyl substituted by SO2NH2, SO3H, PO3H2, CONHOH or a heterocyclic group selected from